Evidence map›Paper›PMID 21726629›Full record

ArticleCellular signalling2011

Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Jacqueline Sayyah, Kavitha Gnanasambandan, Sushama Kamarajugadda, Shigeharu Tsuda, Jennifer Caldwell-Busby, Peter P Sayeski

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jacqueline SayyahDepartment of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA.
Kavitha Gnanasambandan
Sushama Kamarajugadda
Shigeharu Tsuda
Jennifer Caldwell-Busby
Peter P Sayeski
University of Florida · USScripps Research Institute · US

Funding

The Role of Jak2 in Angiotensin II SignalingR01HL067277 · NHLBI · UNIVERSITY OF FLORIDA · PI SAYESKI, PETER P · 2002 to 2011
$2.9M
NHLBI NIH HHS R01 HL067277NHLBI NIH HHS R01-HL67277
6 · The paper itself

Abstract

Jak2 tyrosine kinase plays an important role in cytokine mediated signal transduction. There are 49 tyrosine residues in Jak2 and phosphorylation of some of these are known to play important roles in the regulation of Jak2 kinase activity. Here, using mass spectrometry, we identified tyrosine residues Y372 and Y373 as novel sites of Jak2 phosphorylation. Mutation of Y372 to F (Y372F) significantly inhibited Jak2 phosphorylation, including that of Y1007, whereas the Jak2-Y373F mutant displayed only modest reduction in phosphorylation. Relative to Jak2-WT, the ability of Jak2-Y372F to bind to and phosphorylate STAT1 was decreased, resulting in reduced Jak2-mediated downstream gene transcription. While the Y372F mutation had no effect on receptor-independent, hydrogen peroxide-mediated Jak2 activation, it impaired interferon-gamma (IFNγ) and epidermal growth factor (EGF)-dependent Jak2 activation. Interestingly however, the Y372F mutant exhibited normal receptor binding properties. Finally, co-expression of SH2-Bβ only partially restored the activation of the Jak2-Y372F mutant suggesting that the mechanism whereby phosphorylation of Y372 is important for Jak2 activation is via dimerization. As such, our results indicate that Y372 plays a critical yet differential role in Jak2 activation and function via a mechanism involving Jak2 dimerization and stabilization of the active conformation.

Indexed as

Gene Expression RegulationJanus Kinase 2AnimalsChlorocebus aethiopsCOS CellsDimerizationEnzyme ActivationEpidermal Growth FactorHydrogen PeroxideInterferon-gammaMass SpectrometryMiceMice, KnockoutMutationPhosphorylationPlasmidsEpidermal Growth FactorHydrogen PeroxideInterferon-gammaJanus Kinase 2STAT1 Transcription FactorTyrosine

Identifiers

PMID21726629
PMCPMC3156348
OpenAlexW1994336438

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.